Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening

Chen, 2016, Cancer statistics in China, 2015, CA Cancer J Clin, 66, 115, 10.3322/caac.21338 Liu, 2018, Incidence and mortality of lung cancer in China, 2008-2012, Chin J Cancer Res, 30, 580, 10.21147/j.issn.1000-9604.2018.06.02 Zeng, 2018, Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries, Lancet Glob Health, 6, e555, 10.1016/S2214-109X(18)30127-X Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Paci, 2017, Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial, Thorax, 72, 825, 10.1136/thoraxjnl-2016-209825 Pastorino, 2019, Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy, Ann Oncol, 30, 1162, 10.1093/annonc/mdz117 de Koning, 2020, Reduced Lung-Cancer Mortality with volume CT screening in a randomized trial, N Engl J Med, 382, 503, 10.1056/NEJMoa1911793 Zorzi, 2015, Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test, Gut, 64, 784, 10.1136/gutjnl-2014-307508 Rex, 2017, Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer, Gastroenterology, 153, 307, 10.1053/j.gastro.2017.05.013 Helsingen, 2019, Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline, BMJ, 367, l5515, 10.1136/bmj.l5515 World Health Organization. https://www.who.int/cancer/detection/colorectalcancer/en/ (accessed July, 8 2020). Zhou, 2014, Demonstration program of population-based lung cancer screening in China: Rationale and study design, Thorac Cancer, 5, 197, 10.1111/1759-7714.12078 Yang, 2020, Epidemiology of lung cancer and lung cancer screening programs in China and the United States, Cancer Lett, 468, 82, 10.1016/j.canlet.2019.10.009 Gohagan, 2004, Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute, Chest, 126, 114, 10.1378/chest.126.1.114 Becker, 2020, Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial, Int J Cancer, 146, 1503, 10.1002/ijc.32486 Gohagan, 2005, Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer, Lung Cancer, 47, 9, 10.1016/j.lungcan.2004.06.007 Henschke, 1999, Early Lung Cancer Action Project: overall design and findings from baseline screening, Lancet, 354, 99, 10.1016/S0140-6736(99)06093-6 Swensen, 2002, Screening for lung cancer with low-dose spiral computed tomography, Am J Respir Crit Care Med, 165, 508, 10.1164/ajrccm.165.4.2107006 van der Aalst, 2016, Lung cancer screening: latest developments and unanswered questions, Lancet Respir Med, 4, 749, 10.1016/S2213-2600(16)30200-4 Gong, 2018, The implementation and first-round results of a community-based colorectal cancer screening program in Shanghai, China, Oncologist, 23, 928, 10.1634/theoncologist.2017-0451 Osborne, 2017, Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?, BMC Public Health, 18, 81, 10.1186/s12889-017-4634-8 Kapidzic, 2014, Attendance and yield over three rounds of population-based fecal immunochemical test screening, Am J Gastroenterol, 109, 1257, 10.1038/ajg.2014.168 Passamonti, 2018, A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer, Gut, 67, 485, 10.1136/gutjnl-2016-312716 Adler, 2014, Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany, BMC Gastroenterol, 14, 183, 10.1186/1471-230X-14-183 Sverzellati, 2016, Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen, Eur Radiol, 26, 3821, 10.1007/s00330-016-4228-3 Patz, 2016, Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial, Lancet Oncol, 17, 590, 10.1016/S1470-2045(15)00621-X